Breast cancer: are imaging studies cost effective following breast cancer and adjuvant therapy?
Prager
D
D
Fairgrounds Medical Center, Allentown, PA, USA.
Grundfest-Broniatowski
S
S
Lerner
H J
HJ
Margolese
R G
RG
Dimitrov
N
N
Silverman
P
P
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000517:prevention & control / Q000601:surgery*; D018270:Carcinoma, Ductal, Breast / Q000517:prevention & control / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003362:Cost-Benefit Analysis; D003520:Cyclophosphamide / Q000008:administration & dosage; D003952:Diagnostic Imaging / Q000191:economics*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D015412:Mastectomy, Segmental; D008727:Methotrexate / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D016896:Treatment Outcome
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate